Paediatric Formulation: Design and Development
Abstract
:1. Introduction
2. Articles in This Special Issue
3. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Allen, L.V. Dosage form design and development. Clin. Ther. 2008, 30, 2102–2111. [Google Scholar] [CrossRef]
- Lopalco, A.; Denora, N.; Laquintana, V.; Cutrignelli, A.; Franco, M.; Robota, M.; Hauschildt, N.; Mondelli, F.; Arduino, I.; Lopedota, A. Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration. Int. J. Pharm. 2020, 574, 118922. [Google Scholar] [CrossRef]
- Laquintana, V.; Asim, M.H.; Lopedota, A.; Cutrignelli, A.; Lopalco, A.; Franco, M.; Bernkop-Schnürch, A.; Denora, N. Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation. Int. J. Pharm. 2019, 572, 118820. [Google Scholar] [CrossRef]
- Lopalco, A.; Curci, A.; Lopedota, A.; Cutrignelli, A.; Laquintana, V.; Franco, M.; Denora, N. Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate. Eur. J. Pharm. Sci. 2019, 127, 339–350. [Google Scholar] [CrossRef]
- Kearns, G.L.; Abdel-Rahman, S.M.; Alander, S.W.; Blowey, D.L.; Leeder, J.S.; Kauffman, R.E. Developmental pharmacology—Drug disposition, action and therapy in infants and children. N. Engl. J. Med. 2003, 349, 1157–1167. [Google Scholar] [CrossRef]
- Perrone, M.; Lopalco, A.; Lopedota, A.; Cutrignelli, A.; Laquintana, V.; Douglas, J.; Franco, M.; Liberati, E.; Russo, V.; Tongiani, S.; et al. Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery. Eur. J. Pharm. Biopharm. 2017, 119, 161–169. [Google Scholar] [CrossRef] [PubMed]
- Perrone, M.; Lopalco, A.; Lopedota, A.; Cutrignelli, A.; Laquintana, V.; Franco, M.; Bernkop-Schnürch, A.; Denora, N. S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery. Eur. J. Pharm. Biopharm. 2018, 132, 103–111. [Google Scholar] [CrossRef] [PubMed]
- Shawahna, R. Pediatric Biopharmaceutical Classification System: Using Age-Appropriate Initial Gastric Volume. AAPS J. 2016, 18, 728–736. [Google Scholar] [CrossRef] [Green Version]
- delMoral-Sanchez, J.M.; Gonzalez-Alvarez, I.; Gonzalez-Alvarez, M.; Navarro, A.; Bermejo, M. Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System. Pharmaceutics 2019, 11, 567. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Matawo, N.; Adeleke, O.A.; Wesley-Smith, J. Optimal Design, Characterization and Preliminary Safety Evaluation of an Edible Orodispersible Formulation for Pediatric Tuberculosis Pharmacotherapy. Int. J. Mol. Sci. 2020, 21, 5714. [Google Scholar] [CrossRef]
- Morris, J.B.; Tisi, D.A.; Tan, D.C.T.; Worthington, J.H. Development and Palatability Assessment of Norvir® (Ritonavir) 100 mg Powder for Pediatric Population. Int. J. Mol. Sci. 2019, 20, 1718. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Albertini, B.; Perissutti, B.; Bertoni, S.; Zanolla, D.; Franceschinis, E.; Voinovich, D.; Lombardo, F.; Keiser, J.; Passerini, N. Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment. Int. J. Mol. Sci. 2019, 20, 1233. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Abramson, D.H. Retinoblastoma: Saving life with vision. Annu. Rev. Med. 2014, 65, 171–184. [Google Scholar] [CrossRef] [PubMed]
- Chantada, G.; Schaiquevich, P. Management of retinoblastoma in children: Current status. Paediatr. Drugs 2015, 17, 185–198. [Google Scholar] [CrossRef] [PubMed]
- Winter, U.; Aschero, R.; Fuentes, F.; Buontempo, F.; Zugbi, S.; Sgroi, M.; Sampor, C.; Abramson, D.H.; Carcaboso, A.M.; Schaiquevich, P. Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration. Int. J. Mol. Sci. 2019, 20, 1077. [Google Scholar] [CrossRef] [Green Version]
- Cutrignelli, A.; Sanarica, F.; Lopalco, A.; Lopedota, A.; Laquintana, V.; Franco, M.; Boccanegra, B.; Mantuano, P.; De Luca, A.; Denora, N. Dasatinib/HP-β-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders. Int. J. Mol. Sci. 2019, 20, 591. [Google Scholar] [CrossRef] [Green Version]
- Kalmanti, L.; Saussele, S.; Lauseker, M.; Müller, M.C.; Dietz, C.T.; Heinrich, L.; Hanfstein, B.; Proetel, U.; Fabarius, A.; Krause, S.W.; et al. Safety and efficacy of imatinib in CML over a period of 10 years: Data from the randomized CML-study IV. Leukemia 2015, 29, 1123–1132. [Google Scholar] [CrossRef]
- FDA Approved Dasatinib for Pediatric Patients. Available online: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-dasatinib-pediatric-patients-cml (accessed on 20 January 2020).
- FDA Approves Nilotinib Pediatric Patients. Available online: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nilotinib-pediatric-patients-newly-diagnosed-or-resistantintolerant-ph-cml-chronic (accessed on 20 January 2020).
- Carofiglio, F.; Lopalco, A.; Lopedota, A.; Cutrignelli, A.; Nicolotti, O.; Denora, N.; Stefanachi, A.; Leonetti, F. Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML. Int. J. Mol. Sci. 2020, 21, 4469. [Google Scholar] [CrossRef]
- Trofimiuk, M.; Wasilewska, K.; Winnicka, K. How to Modify Drug Release in Paediatric Dosage Forms? Novel Technologies and Modern Approaches with Regard to Children’s Population. Int. J. Mol. Sci. 2019, 20, 3200. [Google Scholar] [CrossRef] [Green Version]
- O’Brien, F.; Clapham, D.; Krysiak, K.; Batchelor, H.; Field, P.; Caivano, G.; Pertile, M.; Nunn, A.; Tuleu, C. Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine. Int. J. Mol. Sci. 2019, 20, 2688. [Google Scholar] [CrossRef] [Green Version]
- Rigante, D.; Lopalco, G.; Vitale, A.; Lucherini, O.M.; Caso, F.; De Clemente, C.; Molinaro, F.; Messina, M.; Costa, L.; Atteno, M.; et al. Untangling the web of systemic autoinflammatory diseases. Mediat. Inflamm. 2014, 2014, 948154. [Google Scholar] [CrossRef] [PubMed]
- Cattalini, M.; Soliani, M.; Rigante, D.; Lopalco, G.; Iannone, F.; Galeazzi, M.; Cantarini, L. Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease. Mediat. Inflamm. 2015, 2015, 570418. [Google Scholar] [CrossRef] [PubMed]
- Vitale, A.; Sota, J.; Rigante, D.; Lopalco, G.; Molinaro, F.; Messina, M.; Iannone, F.; Cantarini, L. Relapsing Polychondritis: An Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives. Curr. Rheumatol. Rep. 2016, 18, 3. [Google Scholar] [CrossRef] [PubMed]
- Bettiol, A.; Lopalco, G.; Emmi, G.; Cantarini, L.; Urban, M.L.; Vitale, A.; Denora, N.; Lopalco, A.; Cutrignelli, A.; Lopedota, A.; et al. Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases. Int. J. Mol. Sci. 2019, 20, 1898. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lopalco, A.; Denora, N. Paediatric Formulation: Design and Development. Int. J. Mol. Sci. 2020, 21, 7118. https://doi.org/10.3390/ijms21197118
Lopalco A, Denora N. Paediatric Formulation: Design and Development. International Journal of Molecular Sciences. 2020; 21(19):7118. https://doi.org/10.3390/ijms21197118
Chicago/Turabian StyleLopalco, Antonio, and Nunzio Denora. 2020. "Paediatric Formulation: Design and Development" International Journal of Molecular Sciences 21, no. 19: 7118. https://doi.org/10.3390/ijms21197118
APA StyleLopalco, A., & Denora, N. (2020). Paediatric Formulation: Design and Development. International Journal of Molecular Sciences, 21(19), 7118. https://doi.org/10.3390/ijms21197118